Researchers are being asked to simplify the "cocktail" of protease inhibitators so AIDS patients don't have to take so many pills each day. Physicians attending the World AIDS Conference in Switzerland complained that the regimen, initially hailed as a breakthrough that gave years of life to people with HIV, is too complicated. Skipping a few doses allows the virus to mutate into forms that are resistant to protease inhibitors.